Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanfang Fan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Medical Sciences|March 9, 2026
Role of the RBMS Family in Different Cancers and Research ProgressHanchi Wu, Rui Hou, Yuhan Zhang, et al.
Frontiers in Immunology|November 27, 2025
Effect of angiotensin II receptor blockers on efficacy and safety of Camrelizumab plus chemotherapy in the first-line therapy for advanced non-small cell lung cancer (ARMOR I): a protocol for a prospective, real-world, multicenter, intervention clinical trialZeyu Wang, Huiyu Wang, Rui Hou, et al.
International Journal of Oncology|February 28, 2025
Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review)Rui Hou, Xi Wu, Cenzhu Wang, et al.
Frontiers in Immunology|March 25, 2026
Correction: Collagen-mediated pro-tumorigenic MAPK activation drives stromal-immune reprogramming in solid cancersJunli Ding, Hongxin Lin, Hanfang Fan, et al.
International Journal of Medical Sciences|June 16, 2025
The interaction network between intestinal flora and cell death in microecosystem of pan-cancersYuhan Zhang, Cenzhu Wang, Tingyan Ruan, et al.
Frontiers in Immunology|March 25, 2026
Collagen-mediated pro-tumorigenic MAPK activation drives stromal-immune reprogramming in solid cancersJunli Ding, Hongxin Lin, Hanfang Fan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 17, 2025
Intratumoral Collagen Deposition Supports Angiogenesis Suggesting Anti-angiogenic Therapy in Armored and Cold TumorsJie Mei, Kai Yang, Xinkang Zhang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Medical Sciences|March 9, 2026
Role of the RBMS Family in Different Cancers and Research ProgressHanchi Wu, Rui Hou, Yuhan Zhang, et al.
Frontiers in Immunology|November 27, 2025
Effect of angiotensin II receptor blockers on efficacy and safety of Camrelizumab plus chemotherapy in the first-line therapy for advanced non-small cell lung cancer (ARMOR I): a protocol for a prospective, real-world, multicenter, intervention clinical trialZeyu Wang, Huiyu Wang, Rui Hou, et al.
International Journal of Oncology|February 28, 2025
Tumor‑associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review)Rui Hou, Xi Wu, Cenzhu Wang, et al.
Frontiers in Immunology|March 25, 2026
Correction: Collagen-mediated pro-tumorigenic MAPK activation drives stromal-immune reprogramming in solid cancersJunli Ding, Hongxin Lin, Hanfang Fan, et al.
International Journal of Medical Sciences|June 16, 2025
The interaction network between intestinal flora and cell death in microecosystem of pan-cancersYuhan Zhang, Cenzhu Wang, Tingyan Ruan, et al.
Frontiers in Immunology|March 25, 2026
Collagen-mediated pro-tumorigenic MAPK activation drives stromal-immune reprogramming in solid cancersJunli Ding, Hongxin Lin, Hanfang Fan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 17, 2025
Intratumoral Collagen Deposition Supports Angiogenesis Suggesting Anti-angiogenic Therapy in Armored and Cold TumorsJie Mei, Kai Yang, Xinkang Zhang, et al.
Pageof 1